T2 Biosystems, Inc.
TTOO Healthcare Diagnostics & Research
T2 Biosystems, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $7.2 million, down 67.8% from fiscal 2022. Operating cash flow growth for three consecutive years.
Follow TTOO
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
73.49 | 41.80 | 50.81 | 11.03 | 42.19 | 32.24 | 10.33 | 15.69 |
Receivables |
0.33 | 0.47 | 1.79 | 2.83 | 5.10 | 5.13 | 2.16 | 1.42 |
Inventory |
0.80 | 1.34 | 2.68 | 3.60 | 3.64 | 3.91 | 4.29 | 4.82 |
Total current assets |
75.44 | 44.32 | 56.61 | 18.90 | 53.58 | 44.39 | 19.36 | 25.19 |
Property, Plant, Equpment (Net) |
13.59 | 10.02 | 7.32 | 5.85 | 3.77 | 4.68 | 4.53 | 1.66 |
Long-Term Investments |
0.26 | 0.26 | — | — | 10.00 | — | — | — |
Long-term assets (Other) |
0.54 | 0.53 | 0.39 | 0.39 | 0.69 | 1.70 | 1.69 | 0.56 |
Total non-current assets |
14.13 | 10.54 | 7.70 | 9.59 | 25.49 | 16.15 | 14.97 | 9.61 |
Total Assets |
89.57 | 54.86 | 64.31 | 28.49 | 79.08 | 60.54 | 34.33 | 34.80 |
Notes Payable |
1.27 | 40.70 | 42.37 | 42.90 | — | — | — | 41.28 |
Accounts Payable |
0.96 | 0.65 | 0.74 | 3.75 | 2.06 | 2.83 | 1.30 | 1.53 |
Accrued Expenses |
4.91 | 6.22 | 6.07 | 11.21 | 7.51 | 7.16 | 7.27 | 9.71 |
Current Revenue (Deferred) |
2.45 | 1.74 | 0.70 | 0.29 | 0.23 | 0.52 | 0.17 | 0.22 |
Other current liabilities |
0.30 | 2.48 | 2.41 | 2.43 | 6.59 | 7.68 | 0.04 | 1.79 |
Total current liabilities |
9.89 | 51.78 | 52.30 | 60.57 | 9.80 | 11.69 | 10.13 | 56.15 |
Long Term Debt (Total) |
40.30 | 1.74 | 0.49 | 1.87 | 45.24 | 47.79 | 49.65 | — |
Non-current Revenue (Deferred) |
— | 0.00 | 0.13 | 0.05 | 0.42 | 0.03 | 0.05 | 0.08 |
Non-current Liabilities (Other) |
0.05 | 0.73 | 0.49 | — | 4.36 | 4.58 | 5.94 | — |
Total non-current liabilities |
40.35 | 1.74 | 0.63 | 1.92 | 60.55 | 61.75 | 63.85 | 6.68 |
Total liabilities |
50.23 | 53.52 | 52.92 | 62.49 | 70.35 | 73.44 | 73.98 | 62.83 |
Additional Paid In Capital |
243.00 | 267.42 | 328.51 | 342.12 | 431.54 | 459.31 | 494.56 | 556.26 |
Common Stock (Net) |
0.03 | 0.04 | 0.04 | 0.05 | 0.15 | 0.00 | 0.01 | 0.00 |
Retained Earnings |
(203.69) | (266.12) | (317.17) | (376.18) | (422.97) | (472.22) | (534.22) | (584.30) |
Common Equity (Total) |
39.34 | 1.34 | 11.39 | (34.00) | 8.73 | (12.90) | (39.65) | (28.04) |
Shareholders Equity (Total) |
39.34 | 1.34 | 11.39 | (34.00) | 8.73 | (12.90) | (39.65) | (28.04) |
Shareholders Equity and Liabilities (Total) |
89.57 | 54.86 | 64.31 | 28.49 | 79.08 | 60.54 | 34.33 | 34.80 |
Shares (Common) |
0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.08 | 4.06 |
Shares (Preferred) |
— | — | — | — | — | — | — | 0.09 |
Shareholders Equity (Tangible) |
39.34 | 1.34 | 11.39 | (34.00) | 8.73 | (12.90) | (39.65) | (28.04) |
Net Debt |
(33.19) | (40.06) | (50.31) | (9.16) | 3.05 | 15.55 | 39.32 | (15.69) |
Total Debt |
40.30 | 1.74 | 0.49 | 1.87 | 45.24 | 47.79 | 49.65 | — |